Home › Research › Treatments
L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results
Burke WJ, Ranno AE, Roccaforte WH, Wengel SP, Bayer BL, Willcockson NK.. Journal of the American Geriatrics Society, 1993-04-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Objective To examine the short-term cognitive and behavioral effects of L-deprenyl in persons with mild dementia of the Alzheimer type (DAT) over a 2-month period. Design A 15-month randomized, double-blind, placebo-controlled trial using a parallel-group design. This report deals with the first 2 months of the trial. Participants 39 subjects with mild DAT (CDR 1) selected using NINCDS-ADRDA criteria. Measures A battery of neuropsychological tests and clinical rating scales. Results The placebo and L-deprenyl subjects were similar at baseline on the clinical and neuropsychological tests. There was no evidence of a L-deprenyl effect on any clinical or neuropsychological measures after 2 months. Conclusion L-deprenyl did not have a measurable impact on behavior or cognitive function over a 2-month period in this group of subjects with mild DAT.
What this study adds
Evidence grade: High
This is a trial of 39 participants. In this 2-month report from a trial of 39 people with mild dementia of the Alzheimer type, L-deprenyl had no measurable effect on behavior or cognitive function compared with placebo. The authors concluded L-deprenyl did not have a measurable impact over this period.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Burke, W. J., Ranno, A. E., Roccaforte, W. H., Wengel, S. P., Bayer, B. L., & Willcockson, N. K. (1993). L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1993.tb06942.x
Vancouver
Burke WJ, Ranno AE, Roccaforte WH, Wengel SP, Bayer BL, Willcockson NK. L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results. Journal of the American Geriatrics Society. 1993. doi:10.1111/j.1532-5415.1993.tb06942.x. PMID: 8463521.
BibTeX
@article{burke1993-8463521,
author = {Burke, W. J. and Ranno, A. E. and Roccaforte, W. H. and Wengel, S. P. and Bayer, B. L. and Willcockson, N. K.},
title = {{L-deprenyl in the treatment of mild dementia of the Alzheimer type: preliminary results}},
journal = {Journal of the American Geriatrics Society},
year = {1993},
doi = {10.1111/j.1532-5415.1993.tb06942.x},
pmid = {8463521},
url = {https://doi.org/10.1111/j.1532-5415.1993.tb06942.x}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results The placebo and L-deprenyl subjects were similar at baseline on the clinical and neuropsychological tests.
Why it matters
In this 2-month report from a trial of 39 people with mild dementia of the Alzheimer type, L-deprenyl had no measurable effect on behavior or cognitive function compared with placebo. The authors concluded L-deprenyl did not have a measurable impact over this period.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Participants39
- Evidence strengthHigh
How this study scored 53/100
Published in a peer-reviewed journal, and it is a randomized controlled trial. Scored zero for effect reported because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 51 of the 96 points we could judge it on, which is 53 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of the American Geriatrics Society) |
| Journal's citation record | 3 / 4 | Journal of the American Geriatrics Society: journal h-index 344 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomized controlled trial (from PubMed type “Randomized Controlled Trial”) |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1993 — older than 20 years, still counted |
| Sample size | 1 / 4 | 39 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 2 / 2 | Randomized and blinded or placebo-controlled (as stated in the record) |
| Times cited | 3 / 7 | Cited 18 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 35 year(s) since 1993 |
| Impact for its field and year | 2 / 6 | Cited 1.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Nancy K. Willcockson holds only 9 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | University of Nebraska Medical Center: institution h-index 666 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 8463521) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 51 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 51 of the 96 points we could judge it on is 53 out of 100. |
| Total | 53 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Treatments from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.